Valdés M, García L, Treserra J, de Pablo J, de Flores T
Department of Psychiatry and Medical Psychology, School of Medicine, University of Barcelona, Spain.
J Affect Disord. 1989 Jan-Feb;16(1):21-5. doi: 10.1016/0165-0327(89)90050-5.
A sample of 31 patients of both sexes suffering from psychogenic pain disorder (DSM-III) were studied in order to test if their clinical and biological features as well as their response to antidepressant treatment support the hypothesis that relates this syndrome to depressive disorders. Biological variables were basal cortisol and dexamethasone suppression test, and treatment consisted of daily administration of 100-175 mg of imipramine for a period of 5 months. Mood state was evaluated by the Hamilton scale and pain was assessed through visual analogue scales immediately before starting treatment and 3 months later. There was a low prevalence of non-suppressors (9.6%) and all patients significantly improved in mood and pain after antidepressant treatment. However, general results support both the hypothesis linking psychogenic pain to depressive disorders and its possible understanding in terms of failed adjustment processes.
对31名患有心因性疼痛障碍(DSM-III)的男女患者样本进行了研究,以检验他们的临床和生物学特征以及对抗抑郁治疗的反应是否支持将该综合征与抑郁症相关联的假说。生物学变量为基础皮质醇和地塞米松抑制试验,治疗方法是每天服用100-175毫克丙咪嗪,持续5个月。在开始治疗前及3个月后,通过汉密尔顿量表评估情绪状态,并通过视觉模拟量表评估疼痛。非抑制者的患病率较低(9.6%),所有患者在接受抗抑郁治疗后情绪和疼痛均有显著改善。然而,总体结果既支持心因性疼痛与抑郁症相关联的假说,也支持从调节过程失败的角度对其进行理解。